Impaired formation of β-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism

J. A. Heinsimer, A. O. Davies, R. W. Downs, M. A. Levine, Allen M. Spiegel, M. K. Drezner, A. De Lean, K. A. Wreggett, M. G. Caron, R. J. Lefkowitz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyroidism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared β-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45% of control), five patients with PHP-Ib (N = 97%), and five control subjects. Competition curves that were generated by increasing concentrations of the β-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors < 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P < 0.02) to the right as a result of a significant (P < 0.01) decrease in the percent of β-adrenergic receptors in the high affinity state from 64 ± 22% in PHP-Ib and 56 ± 5% in controls to 10 ± 8% in PHP-Ia. The agonist competition curves were computer fit to a 'ternary complex' model for the two-step reaction: H + R + N ≠ HR + N ⇆ HRN. The modeling was consistent with a 60% decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H.E., and A.S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, wereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.

Original languageEnglish (US)
Pages (from-to)1335-1343
Number of pages9
JournalJournal of Clinical Investigation
Volume73
Issue number5
StatePublished - 1984
Externally publishedYes

Fingerprint

Pseudohypoparathyroidism
Adrenergic Receptors
Adenylyl Cyclases
Nucleotides
Proteins
Isoproterenol
Erythrocytes
Pindolol
Adrenergic Agonists
Erythrocyte Membrane
GTP-Binding Proteins
Molecular Biology
Cell Membrane
Hormones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Heinsimer, J. A., Davies, A. O., Downs, R. W., Levine, M. A., Spiegel, A. M., Drezner, M. K., ... Lefkowitz, R. J. (1984). Impaired formation of β-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism. Journal of Clinical Investigation, 73(5), 1335-1343.

Impaired formation of β-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism. / Heinsimer, J. A.; Davies, A. O.; Downs, R. W.; Levine, M. A.; Spiegel, Allen M.; Drezner, M. K.; De Lean, A.; Wreggett, K. A.; Caron, M. G.; Lefkowitz, R. J.

In: Journal of Clinical Investigation, Vol. 73, No. 5, 1984, p. 1335-1343.

Research output: Contribution to journalArticle

Heinsimer, JA, Davies, AO, Downs, RW, Levine, MA, Spiegel, AM, Drezner, MK, De Lean, A, Wreggett, KA, Caron, MG & Lefkowitz, RJ 1984, 'Impaired formation of β-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism', Journal of Clinical Investigation, vol. 73, no. 5, pp. 1335-1343.
Heinsimer, J. A. ; Davies, A. O. ; Downs, R. W. ; Levine, M. A. ; Spiegel, Allen M. ; Drezner, M. K. ; De Lean, A. ; Wreggett, K. A. ; Caron, M. G. ; Lefkowitz, R. J. / Impaired formation of β-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism. In: Journal of Clinical Investigation. 1984 ; Vol. 73, No. 5. pp. 1335-1343.
@article{26dbec8a79ca44a9bf54af64f04be233,
title = "Impaired formation of β-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism",
abstract = "Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyroidism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared β-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45{\%} of control), five patients with PHP-Ib (N = 97{\%}), and five control subjects. Competition curves that were generated by increasing concentrations of the β-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors < 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P < 0.02) to the right as a result of a significant (P < 0.01) decrease in the percent of β-adrenergic receptors in the high affinity state from 64 ± 22{\%} in PHP-Ib and 56 ± 5{\%} in controls to 10 ± 8{\%} in PHP-Ia. The agonist competition curves were computer fit to a 'ternary complex' model for the two-step reaction: H + R + N ≠ HR + N ⇆ HRN. The modeling was consistent with a 60{\%} decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H.E., and A.S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, wereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.",
author = "Heinsimer, {J. A.} and Davies, {A. O.} and Downs, {R. W.} and Levine, {M. A.} and Spiegel, {Allen M.} and Drezner, {M. K.} and {De Lean}, A. and Wreggett, {K. A.} and Caron, {M. G.} and Lefkowitz, {R. J.}",
year = "1984",
language = "English (US)",
volume = "73",
pages = "1335--1343",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Impaired formation of β-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism

AU - Heinsimer, J. A.

AU - Davies, A. O.

AU - Downs, R. W.

AU - Levine, M. A.

AU - Spiegel, Allen M.

AU - Drezner, M. K.

AU - De Lean, A.

AU - Wreggett, K. A.

AU - Caron, M. G.

AU - Lefkowitz, R. J.

PY - 1984

Y1 - 1984

N2 - Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyroidism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared β-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45% of control), five patients with PHP-Ib (N = 97%), and five control subjects. Competition curves that were generated by increasing concentrations of the β-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors < 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P < 0.02) to the right as a result of a significant (P < 0.01) decrease in the percent of β-adrenergic receptors in the high affinity state from 64 ± 22% in PHP-Ib and 56 ± 5% in controls to 10 ± 8% in PHP-Ia. The agonist competition curves were computer fit to a 'ternary complex' model for the two-step reaction: H + R + N ≠ HR + N ⇆ HRN. The modeling was consistent with a 60% decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H.E., and A.S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, wereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.

AB - Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyroidism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared β-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45% of control), five patients with PHP-Ib (N = 97%), and five control subjects. Competition curves that were generated by increasing concentrations of the β-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors < 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P < 0.02) to the right as a result of a significant (P < 0.01) decrease in the percent of β-adrenergic receptors in the high affinity state from 64 ± 22% in PHP-Ib and 56 ± 5% in controls to 10 ± 8% in PHP-Ia. The agonist competition curves were computer fit to a 'ternary complex' model for the two-step reaction: H + R + N ≠ HR + N ⇆ HRN. The modeling was consistent with a 60% decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H.E., and A.S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, wereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.

UR - http://www.scopus.com/inward/record.url?scp=0021327133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021327133&partnerID=8YFLogxK

M3 - Article

VL - 73

SP - 1335

EP - 1343

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -